Prurigo Nodularis clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • Barzolvolimab in Patients With Prurigo Nodularis

    open to eligible people ages 18 years and up

    The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.

    San Francisco 5391959, California 5332921 and other locations

Last updated: